← Evidence map

ArticleCell2017

Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab.

Nadeem Riaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1,530 papers cite itlatest 60 shown

2017
…
2026
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 29033130